Ardsley Advisory Partners’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-15,000
Closed -$260K 173
2017
Q4
$260K Buy
15,000
+5,000
+50% +$86.7K 0.03% 109
2017
Q3
$277K Buy
+10,000
New +$277K 0.04% 101